Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Comment by PowerofNowon Mar 05, 2021 10:57pm
254 Views
Post# 32735245

RE:RE:The big announcement? IS NO ANNOUNCEMENT

RE:RE:The big announcement? IS NO ANNOUNCEMENTWhats crazy is many basher accounts on this board which are on ignore.... Their first posts started as neutral.  Look at this Scotty low life.  https://stockhouse.com/members/losingmyshirt


GajjarDr wrote: Nice Try MinimumDamage "BASHER". Your first post FROM FEB 26TH .
MinimumDamage wrote:

Feb 26 news release :Company undergoing stock symbol change and renaming company? Wow, impressive news.


March 1 news release :Company states it will focus on developing R-107, their main product line.That's not exactly news but rather stating the obvious.


March 2 news release :Company says nitric oxide may help in treating certain diseases. ( Been known for nearly 2 decades). Feels like this has been told at least a 1000 times by anyone involved in NO since it's discovery in 1998.
 



<< Previous
Bullboard Posts
Next >>